Liver transplantation and non-alcoholic fatty liver disease

World Journal of Gastroenterology

Volumn 20, Issue 42, 2014, Pages 15532-15538

  Zezos, Petros ^a   Renner, Eberhard L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hepatic steatosis; Insulin resistance; Liver cirrhosis; Liver transplantation; Metabolic syndrome; Non alcoholic fatty liver disease; Obesity; Steatohepatitis

Indexed keywords

ALCOHOLISM; ARTICLE; BARIATRIC SURGERY; DISEASE COURSE; END STAGE LIVER DISEASE; EPIDEMIC; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; LABORATORY; LIVER CIRRHOSIS; LIVER GRAFT; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; ORGAN DONOR; OUTCOME ASSESSMENT; POPULATION; PREVALENCE; ADVERSE EFFECTS; DONOR SELECTION; GRAFT SURVIVAL; LIVER TRANSPLANTATION; LIVING DONOR; NON-ALCOHOLIC FATTY LIVER DISEASE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SUPPLY AND DISTRIBUTION; TIME; TREATMENT OUTCOME;

DONOR SELECTION; END STAGE LIVER DISEASE; GRAFT SURVIVAL; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84912080070     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i42.15532     Document Type: Article

References (50)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023 [PMID: 22488764 DOI: 10.1002/hep.25762]
2. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: A global perspective. Semin Liver Dis 2008; 28: 339-350 [PMID: 18956290 DOI: 10.1055/s-0028-1091978]
3. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006; 43: S99-S112 [PMID: 16447287]
4. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-1350 [PMID: 20879883 DOI: 10.1056/NEJMra0912063]
5. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, Younossi ZM. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009; 7: 234-238 [PMID: 19049831 DOI: 10.1016/j.cgh.2008.11.005]
6. Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x]
7. McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006; 40 Suppl 1: S17-S29 [PMID: 16540762]
8. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology 2011; 140: 124-131 [PMID: 20858492 DOI: 10.1053/j.gastro.2010.09.038]
9. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249-1253 [PMID: 21726509 DOI: 10.1053/j.gastro.2011.06.061]
10. Kemmer N, Neff GW, Franco E, Osman-Mohammed H, Leone J, Parkinson E, Cece E, Alsina A. Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation. Transplantation 2013; 96: 860-862 [PMID: 24247899 DOI: 10.1097/01.TP.0000436723.59879.01]
11. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669 [PMID: 10051466]
12. Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006; 40 Suppl 1: S11-S16 [PMID: 16540761]
13. McCormack L, Dutkowski P, El-Badry AM, Clavien PA. Liver transplantation using fatty livers: Always feasible? J Hepatol 2011; 54: 1055-1062 [PMID: 21145846 DOI: 10.1016/j.jhep.2010.11.004]
14. Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl 2006; 12: 523-534 [PMID: 16555318]
15. de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Pleass H, Crawford M, McCaughan GW, Verran DJ. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol 2012; 27: 540-546 [PMID: 21777274 DOI: 10.1111/j.1440-1746.2011.06844.x]
16. Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, Upton MP, Reyes JD, Perkins JD. The biopsied donor liver: Incorporating macrosteatosis into highrisk donor assessment. Liver Transpl 2010; 16: 874-884 [PMID: 20583086 DOI: 10.1002/lt.22085]
17. Selzner M, Rüdiger HA, Sindram D, Madden J, Clavien PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000; 32: 1280-1288 [PMID: 11093735]
18. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: Disruption at two different levels in the regeneration pathway. Hepatology 2000; 31: 35-42 [PMID: 10613725]
19. Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken) 2008; 291: 684-692 [PMID: 18484615 DOI: 10.1002/ar.20715]
20. Selzner N, Selzner M, Jochum W, Amann-Vesti B, Graf R, Clavien PA. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol 2006; 44: 694-701 [PMID: 16229921]
21. Dutkowski P, Schlegel A, Slankamenac K, Oberkofler CE, Adam R, Burroughs AK, Schadde E, Müllhaupt B, Clavien PA. The use of fatty liver grafts in modern allocation systems: Risk assessment by the balance of risk (BAR) score. Ann Surg 2012; 256: 861-868; discussion 868-869 [PMID: 23095632 DOI: 10.1097/SLA.0b013e318272dea2]
22. Kwon CH, Joh JW, Lee KW, Kim SJ, Han YS, Park JW, Kim DJ, Park JB, Lee SK. Safety of donors with fatty liver in liver transplantation. Transplant Proc 2006; 38: 2106-2107 [PMID: 16980014]
23. Cho JY, Suh KS, Kwon CH, Yi NJ, Lee KU. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery 2006; 139: 508-515 [PMID: 16627060]
24. Yamamoto K, Takada Y, Fujimoto Y, Haga H, Oike F, Kobayashi N, Tanaka K. Nonalcoholic steatohepatitis in donors for living donor liver transplantation. Transplantation 2007; 83: 257-262 [PMID: 17297396]
25. Ahn JS, Sinn DH, Gwak GY, Kim JM, Kwon CH, Joh JW, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Steatosis among living liver donors without evidence of fatty liver on ultrasonography: Potential implications for preoperative liver biopsy. Transplantation 2013; 95: 1404-1409 [PMID: 23542472 DOI: 10.1097/TP.0b013e31828d1588]
26. Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009; 9: 782-793 [PMID: 19344467 DOI: 10.1111/j.1600-6143.2009.02590.x]
27. Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl 2009; 15: 1814-1820 [PMID: 19938128 DOI: 10.1002/lt.21927]
28. Barritt AS, Dellon ES, Kozlowski T, Gerber DA, Hayashi PH. The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. J Clin Gastroenterol 2011; 45: 372-378 [PMID: 20733515 DOI: 10.1097/MCG.0b013e3181eeaff0]
29. Afzali A, Berry K, Ioannou GN. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl 2012; 18: 29-37 [PMID: 21932374 DOI: 10.1002/lt.22435]
30. Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 2013; 95: 755-760 [PMID: 23370710 DOI: 10.1097/TP.0b013e31827afb3a]
31. Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of liver transplantation for nonalcoholic steatohepatitis: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014; 12: 394-402.e1 [PMID: 24076414]
32. Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology 2012; 56: 1741-1750 [PMID: 22611040 DOI: 10.1002/hep.25855]
33. Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl 2010; 16: 431-439 [PMID: 20373454 DOI: 10.1002/lt.22004]
34. Dureja P, Mellinger J, Agni R, Chang F, Avey G, Lucey M, Said A. NAFLD recurrence in liver transplant recipients. Transplantation 2011; 91: 684-689 [PMID: 21248661 DOI: 10.1097/TP.0b013e31820b6b84]
35. Watt KD, Charlton MR. Metabolic syndrome and liver transplantation: A review and guide to management. J Hepatol 2010; 53: 199-206 [PMID: 20451282 DOI: 10.1016/j.jhep.2010.01.040]
36. Pagadala M, Dasarathy S, Eghtesad B, McCullough AJ. Post-transplant metabolic syndrome: An epidemic waiting to happen. Liver Transpl 2009; 15: 1662-1670 [PMID: 19938136 DOI: 10.1002/lt.21952]
37. Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z. Metabolic syndrome in liver transplant recipients: Prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011; 17: 15-22 [PMID: 21254340 DOI: 10.1002/lt.22198]
38. Sprinzl MF, Weinmann A, Lohse N, Tönissen H, Koch S, Schattenberg J, Hoppe-Lotichius M, Zimmermann T, Galle PR, Hansen T, Otto G, Schuchmann M. Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation. Transpl Int 2013; 26: 67-74 [PMID: 23126674 DOI: 10.1111/j.1432-2277.2012.01576.x]
39. Seo S, Maganti K, Khehra M, Ramsamooj R, Tsodikov A, Bowlus C, McVicar J, Zern M, Torok N. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl 2007; 13: 844-847 [PMID: 17029282]
40. Lim LG, Cheng CL, Wee A, Lim SG, Lee YM, Sutedja DS, Da Costa M, Prabhakaran K, Wai CT. Prevalence and clinical associations of posttransplant fatty liver disease. Liver Int 2007; 27: 76-80 [PMID: 17241384]
41. Dumortier J, Giostra E, Belbouab S, Morard I, Guillaud O, Spahr L, Boillot O, Rubbia-Brandt L, Scoazec JY, Hadengue A. Non-alcoholic fatty liver disease in liver transplant recipients: Another story of "seed and soil". Am J Gastroenterol 2010; 105: 613-620 [PMID: 20040915 DOI: 10.1038/ajg.2009.717]
42. Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52: 894-903 [PMID: 20684021 DOI: 10.1002/hep.23759]
43. Finkenstedt A, Auer C, Glodny B, Posch U, Steitzer H, Lanzer G, Pratschke J, Biebl M, Steurer M, Graziadei I, Vogel W, Zoller H. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis. Clin Gastroenterol Hepatol 2013; 11: 1667-1672 [PMID: 23872669 DOI: 10.1016/j.cgh.2013.06.025]
44. Watt KD, Dierkhising R, Fan C, Heimbach JK, Tillman H, Goldstein D, Thompson A, Krishnan A, Charlton MR. Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: Insight into mechanisms of disease. Am J Transplant 2013; 13: 2450-2457 [PMID: 23859071 DOI: 10.1111/ajt.12355]
45. Charlton M. Evolving aspects of liver transplantation for nonalcoholic steatohepatitis. Curr Opin Organ Transplant 2013; 18: 251-258 [PMID: 23652610 DOI: 10.1097/MOT.0b013e3283615d30]
46. Van Wagner LB, Rinella ME. The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis. Therap Adv Gastroenterol 2011; 4: 249-263 [PMID: 21765869]
47. Satapathy SK, Nair S, Vanatta JM. Nonalcoholic fatty liver disease following liver transplantation. Hepatol Int 2013; 7: 400-412
48. Newsome PN, Allison ME, Andrews PA, Auzinger G, Day CP, Ferguson JW, Henriksen PA, Hubscher SG, Manley H, McKiernan PJ, Millson C, Mirza D, Neuberger JM, Oben J, Pollard S, Simpson KJ, Thorburn D, Tomlinson JW, Wyatt JS. Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis. Gut 2012; 61: 484-500 [PMID: 22234978 DOI: 10.1136/gutjnl-2011-300886]
49. Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D, Fragopoulou E, Zafiropoulou R, Manios Y, Papatheodoridis G. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014; 33: 678-683 [PMID: 24064253 DOI: 10.1016/j.clnu.2013.08.014]
50. Heimbach JK, Watt KD, Poterucha JJ, Ziller NF, Cecco SD, Charlton MR, Hay JE, Wiesner RH, Sanchez W, Rosen CB, Swain JM. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant 2013; 13: 363-368 [PMID: 23137119 DOI: 10.1111/j.1600-6143.2012.04318.x]